Novartis AG
Site-specific chemoenzymatic protein modifications
Last updated:
Abstract:
The present invention relates to methods and reagents for use in site-selective modification of proteins having lysine residues with functionalized peptides using a chemoenzymatic microbial transglutaminase-mediated reaction. The functionalized proteins may be used for study or therapeutic uses.
Status:
Grant
Type:
Utility
Filling date:
29 Nov 2018
Issue date:
13 Apr 2021